Stay Granted In Lipitor Case Pending Del. Decision

Law360, New York (June 15, 2009, 12:00 AM EDT) -- Pfizer Inc. has won a stay of litigation in a patent dispute over the blockbuster cholesterol drug Lipitor, a move the court says will avoid unnecessarily duplicative litigation against generics maker Apotex Inc.

Fighting the same case in Delaware and Illinois makes little sense, and the Illinois case should be stayed until Delaware decides whether it has jurisdiction, Judge Robert Dow of the U.S. District Court for the Northern District of Illinois said in a ruling issued Friday.

In November, Apotex sent notice to Pfizer of...
To view the full article, register now.